Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis-Reference-Cited by-同舟云学术

Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis

Published:2018-05 Issue:5 Volume:46 Page:691-698
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Iankova Irena,Thompson-Leduc Philippe,Kirson Noam Y.,Rice Bernie,Hey Juliane,Krause Alexander,Schonfeld Sophie A.,DeBrase Christopher R.,Bozzette Samuel,Schuetz Philipp

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference41 articles.

1. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit

2. Infection Rate and Acute Organ Dysfunction Risk as Explanations for Racial Differences in Severe Sepsis

3. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007

4. Epidemiologic trends of sepsis in western countries

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits and Harms of Procalcitonin- or C-Reactive Protein-Guided Antimicrobial Discontinuation in Critically Ill Adults With Sepsis: A Systematic Review and Network Meta-Analysis;Critical Care Medicine;2024-07-01

2. Antimicrobial De-Escalation in Critically Ill Patients;Antibiotics;2024-04-19

3. Infectious Pulmonary Diseases;Infectious Disease Clinics of North America;2024-03

4. The Role of Biomarkers in the Diagnosis and Management of Pneumonia;Infectious Disease Clinics of North America;2024-03

5. Management of Non-Ventilated hospital acquired pneumonia;Clinical Infection in Practice;2024-01